Status:
WITHDRAWN
Acne Scarring in Skin of Color: Laser vs Microneedling
Lead Sponsor:
Boston University
Conditions:
Acne Vulgaris
Scar
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrophic acne scars are a common and important sequelae of acne that affect up to 43-55% of patients with acne. Scarring impacts quality of life with reports of diminished self-esteem and frustration/...
Eligibility Criteria
Inclusion
- Patients referred to dermatology clinic for any reason, or resident or attending dermatologists at Boston University.
- Individuals (men and women) aged 18 and older
- Patients must have atrophic facial acne scarring on the face and desire treatment to improve appearance of acne scarring
- Patients must have Fitzpatrick skin type III-VI
- Patients must be willing to receive five acne scarring treatments at monthly intervals with one follow-up visit to assess for efficacy and adverse effects
- Subjects must speak either English, Chinese, or Spanish.
Exclusion
- Subjects who are unable or unwilling to give informed consent.
- Personal history of photosensitivity or photosensitive diseases.
- Pregnancy or breast-feeding.
- Facial surgical or laser treatment in the last 3 months.
- Patients with any active skin infection in the treatment area.
- Coagulopathies or anticoagulant therapy.
- Personal history or presence of hypertrophic scars or keloids.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03395678
Start Date
November 1 2019
End Date
December 1 2020
Last Update
November 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118